|
|
Post by reality on Aug 11, 2018 17:16:32 GMT -5
Ok I am posting here for the sanity of everyone. I suspect I will get kicked out since this is a cheerleader board as it is but so what-
Here's my honest opinion - you can take it or leave it-
I was with Mannkind when Al Mann was alive and when Sanofi signed a deal with them. I got suckered into to buying the stock at $6, 7,8, 9 and $10 (before the famous Matt P reverse 1-5 split. I also bought at 5, 4, 3, 2, 1, 64 cents and back at $1, 2, 3 back down to $2. I got so tired I sold it all at $2-
In other words, I lost a bunch of money in this stock (a big bunch).
I spoke to Sanofi several times when they were partners, relayed a bunch of info to Matt P, spoke to him countless times as well all Mike C and others.
One thing the Sanofi guy (he was their head of Afrezza sales) told me - stuck with me- nice niche product, hopefully, it will sell.
I didn't believe him. I had my rose-colored eye glasses on -- and continued to have them for another two-three years
Guess I was wrong- I admit it.
Cut your loses. Move on. This company is dead.
Just my advice.
|
|
|
|
Post by sexychefski on Aug 11, 2018 17:27:20 GMT -5
Thank you for the advice. What should I buy instead and should I refinance my house to buy new stock? Thanks internet stranger.
|
|
|
|
Post by cjm18 on Aug 11, 2018 17:31:17 GMT -5
Ok I am posting here for the sanity of everyone. I suspect I will get kicked out since this is a cheerleader board as it is but so what- Here's my honest opinion - you can take it or leave it- I was with Mannkind when Al Mann was alive and when Sanofi signed a deal with them. I got suckered into to buying the stock at $6, 7,8, 9 and $10 (before the famous Matt P reverse 1-5 split. I also bought at 5, 4, 3, 2, 1, 64 cents and back at $1, 2, 3 back down to $2. I got so tired I sold it all at $2- In other words, I lost a bunch of money in this stock (a big bunch). I spoke to Sanofi several times when they were partners, relayed a bunch of info to Matt P, spoke to him countless times as well all Mike C and others. One thing the Sanofi guy (he was their head of Afrezza sales) told me - stuck with me- nice niche product, hopefully, it will sell. I didn't believe him. I had my rose-colored eye glasses on -- and continued to have them for another two-three years Guess I was wrong- I admit it. Cut your loses. Move on. This company is dead. Just my advice. Short of sanofi guy saying niche product and poor past sales...what reasoning do you have that the company is dead. The same sanofi guy raved about cgm results. The size of the diabetes market is simply too large to fail. One percent of the market would be sufficient for now. Selling at this market cap is a mistake if your time horizon remains years. Sell a small portion in December and harvest some losses. |
|
|
|
Post by reality on Aug 11, 2018 17:39:37 GMT -5
Try about 300-500 scripts for the last 4 years
|
|
|
|
Post by reality on Aug 11, 2018 17:44:27 GMT -5
I do empathize. I am in the same boat as everyone and would love it if Mannkind and Afrezza do start selling but I haven't seen it. 5 years is a long time to hold a stock and not get any return and in fact suffer significant loses.
|
|
|
|
Post by ezmit on Aug 11, 2018 18:17:14 GMT -5
You might as well take sanofis launch of afrezza and equal it 2 about a minus one year of sales. Sanofi did jack shit, we all know that. More harm than good imo.
Now subtract the year or so of convincing drs that the product is actually still on the market. And you have a product that hasn't really been marketed for very long. 95% of drs. Either don't know, misunderstand or just flat out don't care about afrezza.
Imo that is slowly starting to change, we are finally starting to get our foot in the diabetes markets door, albeit a pinky toe but its something.
|
|
|
|
Post by cjm18 on Aug 11, 2018 18:39:35 GMT -5
Try about 300-500 scripts for the last 4 years Anything other than past sales aka rear view investing? |
|
|
|
Post by joeypotsandpans on Aug 11, 2018 18:51:54 GMT -5
Ok I am posting here for the sanity of everyone. I suspect I will get kicked out since this is a cheerleader board as it is but so what- Here's my honest opinion - you can take it or leave it- I was with Mannkind when Al Mann was alive and when Sanofi signed a deal with them. I got suckered into to buying the stock at $6, 7,8, 9 and $10 (before the famous Matt P reverse 1-5 split. I also bought at 5, 4, 3, 2, 1, 64 cents and back at $1, 2, 3 back down to $2. I got so tired I sold it all at $2- In other words, I lost a bunch of money in this stock (a big bunch). I spoke to Sanofi several times when they were partners, relayed a bunch of info to Matt P, spoke to him countless times as well all Mike C and others. One thing the Sanofi guy (he was their head of Afrezza sales) told me - stuck with me- nice niche product, hopefully, it will sell. I didn't believe him. I had my rose-colored eye glasses on -- and continued to have them for another two-three years Guess I was wrong- I admit it. Cut your loses. Move on. This company is dead. Just my advice. Hakan is this you, or perhaps it's RS? If you knew at the time that the "head of Sanofi Afrezza sales" was marketing this as a "niche product" shouldn't that have told you something right then and there about Sanofi? LOL!! Take it from one of the "cheerleaders" (damn right I cheer for it every day I take it) that uses it on a daily basis.....it's NOT a niche product, it's everything that you read in the testimonials from all those that currently swear by it. Thanks for your concern enough for me as a shareholder that after you having sold a $2 you decided to drop in on a Saturday afternoon for my "sanity", but unfortunately my body and organs cannot agree with your "niche" assessment and you can take that reality to the bank. Thanks (not) for stopping by. I hope your thread does not get locked just so others can read this  |
|
|
|
Post by liane on Aug 11, 2018 19:01:46 GMT -5
joeypotsandpans Thanks! I love these altruistic "I sold and so should you" posters. Glad you are doing well. It's been a long haul, but things are starting to change.
|
|
|
|
Post by bradleysbest on Aug 11, 2018 19:17:15 GMT -5
Bye Felisha! (Reality) !
|
|
|
|
Post by gareaudan on Aug 11, 2018 19:21:52 GMT -5
Ok I am posting here for the sanity of everyone. I suspect I will get kicked out since this is a cheerleader board as it is but so what- Here's my honest opinion - you can take it or leave it- I was with Mannkind when Al Mann was alive and when Sanofi signed a deal with them. I got suckered into to buying the stock at $6, 7,8, 9 and $10 (before the famous Matt P reverse 1-5 split. I also bought at 5, 4, 3, 2, 1, 64 cents and back at $1, 2, 3 back down to $2. I got so tired I sold it all at $2- In other words, I lost a bunch of money in this stock (a big bunch). I spoke to Sanofi several times when they were partners, relayed a bunch of info to Matt P, spoke to him countless times as well all Mike C and others. One thing the Sanofi guy (he was their head of Afrezza sales) told me - stuck with me- nice niche product, hopefully, it will sell. I didn't believe him. I had my rose-colored eye glasses on -- and continued to have them for another two-three years Guess I was wrong- I admit it. Cut your loses. Move on. This company is dead. Just my advice. wow thank you so so much for taking the time to came here, even if you are not involve in mnkd in any matter, just to save me from myself... I fell so grateful and have hope in humanity again. First thing monday morning im selling every mnkd i own and send you a check for your very wise advises. Thank you again my savior. |
|
|
|
Post by liane on Aug 11, 2018 19:54:36 GMT -5
Ok I am posting here for the sanity of everyone. I suspect I will get kicked out since this is a cheerleader board as it is but so what- Here's my honest opinion - you can take it or leave it- I was with Mannkind when Al Mann was alive and when Sanofi signed a deal with them. I got suckered into to buying the stock at $6, 7,8, 9 and $10 (before the famous Matt P reverse 1-5 split. I also bought at 5, 4, 3, 2, 1, 64 cents and back at $1, 2, 3 back down to $2. I got so tired I sold it all at $2- In other words, I lost a bunch of money in this stock (a big bunch). I spoke to Sanofi several times when they were partners, relayed a bunch of info to Matt P, spoke to him countless times as well all Mike C and others. One thing the Sanofi guy (he was their head of Afrezza sales) told me - stuck with me- nice niche product, hopefully, it will sell. I didn't believe him. I had my rose-colored eye glasses on -- and continued to have them for another two-three years Guess I was wrong- I admit it. Cut your loses. Move on. This company is dead. Just my advice. wow thank you so so much for taking the time to came here, even if you are not involve in mnkd in any matter, just to save me from myself... I fell so grateful and have hope in humanity again. First thing monday morning im selling every mnkd i own and send you a check for your very wise advises. Thank you again my savior.    |
|
|
|
Post by sportsrancho on Aug 11, 2018 21:25:35 GMT -5
Reality is ... The last people that were going to sell sold August 6. To the delight of some of my friends who picked up more cheap shares.
Money has been a problem for sure to market the drug properly. And insurance has cost us many scripts. But there are some people in the camp that think people just don’t want Afrezza. I’m 100% positive that awareness has been the problem. And that by the time Afrezza gets approved for kids we will be on a roll. Red, pink, blue, green, dreamboats will abound:-)
Reality is....Dr. Kendall thinks it’s worth fighting for. I’m hanging in, I wouldn’t want to give up right before we reach those veins of gold!
|
|
|
|
Post by nadathing on Aug 11, 2018 22:41:02 GMT -5
One analyst that I remember called Afrezza a niche drug. I believe it is a niche drug for T2's in the United States. I was diagnosed T2 about 15 years ago. I have posted my reasons for believing that and it is based on discussions with my endo. I believe the real market is T1's and more specifically juvenile T1's. Young people embrace technology and they would most likely figure out titration more quickly than adults. Using a CGM and Afrezza is clearly a winning combination.
SNY said that Afrezza is not commercially viable in the USA. They threw in the towel 6 months after they started selling Afrezza. They went in another direction. Is it that Afrezza really isn't commercially viable or was that their excuse to legally exit the partnership agreement? Afrezza is not yet commercially viable in the USA. Will it be? I hold out hope, but I don't see it happening by targeting T2's. We are working towards approval for juvenile use. In order to achieve success MNKD will have to get doctors to prescribe Afrezza for young patients. Will they do that? That is the multi million dollar question. The company is not dead. Mike has done a good job so far and if financing is worked out I think we will eventually see daylight and profitability.
|
|
|
|
Post by buyitonsale on Aug 12, 2018 0:29:34 GMT -5
Lets face reality... if diabetics were aware of Afrezza and had insurance access they would choose it over any other mealtime insulin.
It’s coming.
|
|
